Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 47
- Adult-Use
Tilray launches first medical cannabis oil in Malta market
After recently expanding further into Europe, the company is adding to its offering in the country.
- CBD Market
Exclusive Charlotte’s Web UK distribution agreement for Savage Cabbage
The new partnership will focus on expanding Charlotte’s Web products into retail and the high street.
- Companies
What does Kanabo’s telehealth approach mean for UK medical cannabis?
Kanabo surprised the market with its £14m acquisition of the GP Service – so, what does this mean for the UK industry and patients?
- CBD Market
Review to establish greater strategic coherence for UK legal cannabis
The Hodges Review has been launched to review regulation and public policy relating to the UK’s industry.
- Adult-Use
Copenhagen proposes five year pilot of recreational cannabis
Legalising links in supply chain is a “precondition for undermining organised crime”, says Denmark.
- Hemp Industry
Maximum THC limit in foods adopted by EU
The European Industrial Hemp Association (EIHA) says the initiative will boost investment in the sector.
- Companies
Alpha Blue Ocean puts more capital in cannabis
The financing will support Halo Collective’s US west coast expansion strategy.
- Companies
Akanda: first UK company listing on NASDAQ with African operations
The company will trade under the ticker AKAN.
- Hemp Industry
Canxchange Q1 2022 benchmark report explores hemp market outlook
The Canxchange Farmers Sentiment Index (CFSI) overall has “collapsed” from its July high.
- Medical
GROW expands into Germany with launch of medical cannabis extracts
Patients in Germany will now benefit from the company’s cannabis medicines.
- Policy & Regulation
Russia raises concerns over EU cannabis legalisation moves
Russian Deputy Foreign Minister Oleg Syromoloto has said there are attempts to “shatter the foundation” of the 1972 Protocol to the Single Convention on Narcotic Drugs of 1961.
- Pharmaceutical
Construction of Tikun’s medical cannabis greenhouse complete
The facility has been completed ahead of schedule.
